Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: A Pediatric Oncology Group study

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 4, 2003, Pages 316-320

  Chauvenet, Allen R ^a,f   Shashi, Vandana ^a   Selsky, Clifford ^b   Morgan, Elaine ^c   Kurtzberg, Joanne ^d   Bell, Beverly ^e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Walt Disney Mem Cancer Institute   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Acute lymphoblastic leukemia; Charcot Marie Tooth; Peripheral neurotoxicity; Vincristine

Indexed keywords

VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; FAMILY HISTORY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; NEUROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEPHAROPTOSIS; CHARCOT-MARIE-TOOTH DISEASE; CHILD, PRESCHOOL; FEMALE; GAIT DISORDERS, NEUROLOGIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; REFLEX, ABNORMAL; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 0037398643     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200304000-00010     Document Type: Article

References (17)

1. Lupski JR, Wise CA, Kuwano A, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1992;1:29-33.
2. Chance PF, Reilly M. Inherited neuropathies. Curr Opin Neurol 1994;7:372-80.
3. De Jonghe P, Timmerman V, Nelis E, et al. Charcot-Marie-Tooth disease and related peripheral neuropathies. J Peripher Nerv Syst 1997;2:370-87.
4. Ionasescu VV, Ionasescu R, Searby CH, et al. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 1995;45:1766-77.
5. Keller MP, Chance PF. Inherited neuropathies: from gene to disease. Brain Pathol 1999;9:327-41.
6. Nelis E, Timmerman V, De Jonghe P, et al. Molecular genetics and biology of inherited peripheral neuropathies: a fast-moving field. Neurogenetics 1999;2: 137-48.
7. Roa BB, Dyck PJ, Marks HG, et al. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5:269-73.
8. Tachi N, Kasai K, Chiba S, et al. Expression of Po protein in sural nerve of a patient with hereditary motor and sensory neuropathy type III. J Neurol Sci 1994;124:67-70.
9. Shaffer LG, Kennedy GM, Spikes AS, et al. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet 1997;69:325-31.
10. Hayasaka K, Himoro M, Sato W, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin PO gene. Nat Genet 1993;5:31-4.
11. De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999;122:281-90.
12. Bergoffen J, Wang S, Scott MO, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039-42.
13. Graf WD, Chance PF, Lensch MW, et al. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 1996;77:1356-61.
14. Owellen RJ, Owens AH, Donigan DW. The binding of vincristine, vinblastine, and colchicine to tubulin. Biochem Biophys Res Commun 1972;47:685-91.
15. Miller R. Epidemiology of leukemia. In Neth R, Gallo R, Hufschneider P, et al., eds. Modern Trends in Human Leukemia. III. New York: Springer-Verlag, 1979.
16. Griffiths JD, Start RJ, Ding JC, et al. Vincristine neurotoxicity in Charcot-Marie Tooth syndrome. Med J Aust 1985;143:305-6.
17. Neumann Y, Toren A, Rechavi G, et al. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol 1996;26:280-3.